Applied Therapeutics, Inc. — Director's Dealing 2025

Jun 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics, Inc. (APLT)
CIK: 0001697532
Period of Report: 2025-06-09

Reporting Person: Lerner Teena (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-09	Stock Option (Right to Buy)	$0.395	A	200000	Acquired	2035-06-09	Common Stock (200000)	Direct

Footnotes

F1: The shares subject to the option will vest in 36 equal monthly installments from the grant date, subject to the Reporting Person's continuous service through such vesting date.